» Articles » PMID: 8984198

Glial Growth Factors I-III Are Specific Mitogens for Glial Cells

Overview
Journal J Neurosci Res
Specialty Neurology
Date 1996 Mar 15
PMID 8984198
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Recently we identified three novel Schwann cell mitogens named GGF (glial growth factor)-I (34 kDa), GGF-II (59 kDa), and GGF-III (45 kDa), and provided evidence that they are three distinct but structurally related members of a larger family of factors, which includes heregulin, neu differentiation factor, and acetylcholine receptor-inducing activity (ARIA). We report here the characterization of the mitogenic and trophic activities for all three forms of GGF on rat Schwann cells and several other cell types. GGF-I, GGF-II, and GGF-III are potent mitogens for rat Schwann cells in vitro at nanomolar concentrations, whereas at lower concentrations they promote Schwann cell survival, in the absence of cAMP elevating agents. Forskolin, an adenylate cyclase activator, potently synergizes with the GGFs by an indirect mechanism, possibly involving transcriptional activation of GGF receptor(s). In addition, the GGFs stimulate DNA synthesis in rat glioma C6 cells, and in SK-BR-3 cells, which overexpress the p185 neu/erbB2. Fibroblasts obtained from different sources are weakly stimulated by GGFs, whereas PC12 cells are unable to respond under a variety of experimental conditions. These observations are consistent with the proposal that GGF-I, GGF-II, and GGF-III are a set of potent glial cell mitogens and putative ligands of members of the EGF receptor family, namely p185 neu/erbB2, p160/erbB3, and p180/erbB4, which may play important roles in the development, regeneration, and tumor biology of the peripheral nervous system.

Citing Articles

Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells.

Pajtler K, Mahlow E, Odersky A, Lindner S, Stephan H, Bendix I Oncotarget. 2014; 5(22):11180-92.

PMID: 25361003 PMC: 4294349. DOI: 10.18632/oncotarget.2611.


Bioengineered nerve regeneration and muscle reinnervation.

Kingham P, Terenghi G J Anat. 2006; 209(4):511-26.

PMID: 17005023 PMC: 2100355. DOI: 10.1111/j.1469-7580.2006.00623.x.


In vivo analysis of Schwann cell programmed cell death in the embryonic chick: regulation by axons and glial growth factor.

Winseck A, Caldero J, Ciutat D, Prevette D, Scott S, Wang G J Neurosci. 2002; 22(11):4509-21.

PMID: 12040058 PMC: 6758805. DOI: 20026391.


Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations.

Thorne R, Frey 2nd W Clin Pharmacokinet. 2001; 40(12):907-46.

PMID: 11735609 DOI: 10.2165/00003088-200140120-00003.


CD44 enhances neuregulin signaling by Schwann cells.

SHERMAN L, Rizvi T, Karyala S, Ratner N J Cell Biol. 2000; 150(5):1071-84.

PMID: 10973996 PMC: 2175255. DOI: 10.1083/jcb.150.5.1071.